Anglo-Swedish pharma major AstraZeneca reports that it will have a historic presence at this year’s American Society of ...

US biotech Moderna (Nasdaq: MRNA) today announced that in consultation with the US Food and Drug Administration (FDA), the ...

Founded in 2021 by Joe Betts-LaCroix and initially funded with $180 million from OpenAI CEO Sam Altman, Retro aims to extend ...

Earlier this month, the US Department of Health and Human Services (HHS) said it would require all future vaccines to undergo ...

The Dementia Discovery Fund (DDF)—managed by healthcare fund manager SV Health Investors—has announced the final closing of ...

Pharmasyntez, one of Russia’s leading drugmakers, plans a significant expansion of its portfolio of innovative drugs in the ...

Swiss reproductive and women’s health medicines specialist ReproNovo today announced the successful closing of a $65 million ...

North Carolina, USA-based vTv Therapeutics (Nasdaq: VTVT) has announced that screening has been reinitiated in the company’s ...

US biotechs Protagenic Therapeutics (Nasdaq: PTIX) and Phytanix Bio have entered into a definitive share exchange agreement ...

UK-based Juvenescence, a clinical stage AI-enabled biotech company, has secured a total of $76 million in the first-close of ...

UK-based PureTech Health (LSE: PRTC) delivered a late-breaking, oral presentation at the 2025 American Thoracic Society (ATS) International Conference in San Francisco. The presentation provided ...

US biotech Tourmaline Bio has reported topline data from a Phase II trial of its lead asset, pacibekitug, in people with chronic kidney disease (CKD) and elevated inflammation levels associated with ...